Life Science Investing Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
Life Science Investing Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress
Life Science Investing Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer 2025 Spring Scientific Meeting
RUA GOLD Expands High-Grade Intercepts at Depth at Auld Creek: 5.9g/t AuEq over 9m and 48.3g/t AuEq over 1.25m
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
